Cargando…

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis

INTRODUCTION: Several lines of evidence suggest that the thyroid hormone signaling pathway is altered in patients with NAFLD and that pharmacological strategies to target the thyroid hormone/thyroid hormone nuclear receptor axis (TH/THR) in the liver may exert beneficial effects. In this study, we i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caddeo, Andrea, Serra, Marina, Sedda, Francesca, Bacci, Andrea, Manera, Clementina, Rapposelli, Simona, Columbano, Amedeo, Perra, Andrea, Kowalik, Marta Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996294/ https://www.ncbi.nlm.nih.gov/pubmed/36910628 http://dx.doi.org/10.3389/fonc.2023.1127517

Ejemplares similares

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
por: Caddeo, Andrea, et al.
Publicado: (2021)

Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease
por: Kowalik, Marta A., et al.
Publicado: (2018)

Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis
por: Kowalik, Marta Anna, et al.
Publicado: (2015)

Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
por: Orrù, Claudia, et al.
Publicado: (2020)

Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2021)

Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma
por: Serra, Marina, et al.
Publicado: (2020)

Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
por: Kowalik, Marta Anna, et al.
Publicado: (2017)

Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration
por: Perra, Andrea, et al.
Publicado: (2020)

Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics
por: Runfola, Massimiliano, et al.
Publicado: (2020)

Diverse MicroRNAs‐mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia
por: Pal, Rajesh, et al.
Publicado: (2022)

A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis
por: Angioni, Maria Maddalena, et al.
Publicado: (2017)

Induction of autophagy promotes the growth of early preneoplastic rat liver nodules
por: Kowalik, Marta Anna, et al.
Publicado: (2015)

Thyromimetics: What does the future hold?
por: Unnikrishnan, A. G., et al.
Publicado: (2012)

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
por: Smiriglia, Alfredo, et al.
Publicado: (2023)

Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease
por: Zhao, Man, et al.
Publicado: (2022)

Design, Synthesis, and In Vitro Evaluation of Novel 8-Amino-Quinoline Combined with Natural Antioxidant Acids
por: Bacci, Andrea, et al.
Publicado: (2022)

mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma
por: Serra, Marina, et al.
Publicado: (2022)

Thyroid Hormones and Thyromimetics: A New Approach to Nonalcoholic Steatohepatitis?
por: Sinha, Rohit A., et al.
Publicado: (2020)

NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis
por: Ma, Chi, et al.
Publicado: (2016)

Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis
por: Tian, Yuan, et al.
Publicado: (2016)

Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases
por: Bacci, Andrea, et al.
Publicado: (2021)

Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC
por: Mattu, Sandra, et al.
Publicado: (2021)

The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice
por: Tancevski, Ivan, et al.
Publicado: (2010)

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
por: Kowalik, Marta Anna, et al.
Publicado: (2016)

Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges
por: Baldassarro, Vito Antonio, et al.
Publicado: (2023)

Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196
por: Hönes, Georg Sebastian, et al.
Publicado: (2022)

Maternal Administration of the CNS-Selective Sobetirome Prodrug Sob-AM2 Exerts Thyromimetic Effects in Murine MCT8-Deficient Fetuses
por: Valcárcel-Hernández, Víctor, et al.
Publicado: (2023)

Recent Developments in NAFLD
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis
por: Jia, Jiaoyuan, et al.
Publicado: (2020)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Alcohol and hepatocarcinogenesis
por: Taniai, Makiko
Publicado: (2020)

Conferring liver selectivity to a thyromimetic using a novel nanoparticle increases therapeutic efficacy in a diet-induced obesity animal model
por: Wu, Ruiling, et al.
Publicado: (2023)

Treatments for NAFLD: State of Art
por: Mantovani, Alessandro, et al.
Publicado: (2021)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism?
por: Serra, Marina, et al.
Publicado: (2020)

Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis
por: Fang, Miao, et al.
Publicado: (2020)

NAFLD: Is There Anything New under the Sun?
por: Lonardo, Amedeo, et al.
Publicado: (2017)

Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)
por: Gonzalez, Andrea, et al.
Publicado: (2020)

Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0
por: Vairetti, Mariapia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ne0cfh8ss539ml55u2jrile8pq